Gastroenterología y Hepatología (English Edition)
Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Rationale and design of the NATURCEL registry: Study of the NATURal history and the epidemiological, clinical, diagnostic and therapeutic aspects of CoELiac disease and noncoeliac enteropathies
Albert Martín-Cardona; Gemma Ibáñez-Sanz; Emma Sudrià-Lopez; Beatriz Arau; Sabela Carballal; Roger Garcia-Puig; Anna Carrasco; Ivan Villar-Balboa; Montse Ibarra; Carme Ferrer; Mireia Fonolleda; Montserrat Planella; Azucena Salas; Sebastián Videla; Carme Loras; Maria Esteve;
Gastroenterol Hepatol. 2026;49:
Open access
High persistence rate at one year- follow-up of subcutaneous vedolizumab at standard dose after switching endovenous vedolizumab, even in those previously intensified: Results of a Spanish multicentre observational study
Laura Andrés; Marisa Iborra; Raquel Vicente; Lara Arias; Pilar Nos; Ana Royo-Esteban; Beatriz Sicilia;
Gastroenterol Hepatol. 2025;48:
Open access
Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease
Carmen Amor Costa; Cristina Suárez Ferrer; Laura García Ramírez; Eduardo Martín-Arranz; Joaquín Poza Cordón; José Luis Rueda García; María Sánchez Azofra; Irene González Diaz; Clara Amiama Roig; María Dolores Martín-Arranz;
Gastroenterol Hepatol. 2025;48:
Open access